Opus Genetics IRD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$49.59M+13.8% | -$57.53M-476% | -$9.99M-156% | $17.89M+132% | ||
| $53K+430% | $10K+66.7% | $6K+50.0% | $4K0.0% | ||
| $3.4M+1.1% | $3.36M-4.2% | $3.51M+94.2% | $1.81M-5.6% | ||
| -$35.25M-37.8% | -$25.58M— | —— | $14.31M+174% | ||
| $0-100% | $1.21M— | $0— | $0-100% | ||
| $0-100% | $1.21M— | $0— | $0+100% | ||
| $50.02M+1,072% | $4.27M-52.5% | $8.98M+136% | $3.8M-86.2% | ||
| —— | -$20.18M— | —— | $18.1M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
